Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results
- PMID: 34782017
- PMCID: PMC8594216
- DOI: 10.1186/s40662-021-00263-1
Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results
Abstract
Background: The short- and medium-term outcomes of iStent have been extensively studied; however, only few studies have investigated its long-term outcomes. Here, we assessed the long-term efficacy and safety of two iStents with concomitant cataract surgery in glaucomatous eyes while also evaluating measures of disease stability using visual field and optical coherence tomography (OCT) of the optic nerve and the macula throughout 8 years of follow-up.
Methods: This longitudinal, single-center consecutive case series included glaucomatous eyes that underwent implantation of two first-generation trabecular micro-bypass stents (iStent) with concomitant cataract surgery. Eight-year efficacy outcomes included mean intraocular pressure (IOP) and medications, as well as surgical success. Eight-year safety outcomes included best-corrected visual acuity (BCVA), visual field mean deviation (VF-MD), cup-to-disc ratio (CDR), retinal nerve fiber layer (RNFL) thickness, ganglion cell-inner plexiform layer (GC-IPL) thickness, and adverse events.
Results: A total of 62 eyes with primary open-angle glaucoma (POAG) were included. At 8 years postoperative, IOP reduced by 26% from 19.2 ± 3.9 mmHg preoperatively to 14.2 ± 2.4 mmHg (P < 0.001), 91.1% of eyes achieved IOP ≤ 18 mmHg (vs. 51.6% preoperatively), 69.6% of eyes achieved IOP ≤ 15 mmHg (vs. 14.5% preoperatively), and 25% of eyes achieved IOP ≤ 12 mmHg (vs. 1.6% preoperatively). Medication use decreased by 17.9% from 2.8 ± 1.1 preoperatively to 2.3 ± 1.2 (P = 0.018). Surgical success was 90%, as six eyes underwent subsequent glaucoma surgeries. Safety measures of BCVA, CDR, RNFL thickness and GC-IPL thickness remained stable through 8 years postoperative. VF-MD remained stable until postoperative year 5 and subsequently progressed according to the natural history of glaucomatous disease.
Conclusions: Implantation of two iStents with concomitant cataract surgery is an effective and safe treatment option for surgery-naïve POAG eyes, evidenced by significant IOP and medication reductions, reasonable surgical success, and favorable safety outcomes, throughout the 8-year follow-up. Our data additionally supports the efficacy of this combined procedure in stabilizing or slowing disease progression.
Keywords: Cataract surgery; Glaucoma; Long-term outcomes; MIGS; Minimally invasive glaucoma surgery; Trabecular micro-bypass stent; iStent.
© 2021. The Author(s).
Conflict of interest statement
Paul Harasymowycz is a consultant for Allergan, Alcon, Glaukos, Ivantis, J and J Vision, Santen, Novartis, and Bausch and Lomb. Ali Salimi and Harrison Watt have nothing to disclose.
Figures





Similar articles
-
Three-Year Outcomes of Second-generation Trabecular Micro-bypass Stents (iStent inject) With Phacoemulsification in Various Glaucoma Subtypes and Severities.J Glaucoma. 2021 Mar 1;30(3):266-275. doi: 10.1097/IJG.0000000000001716. J Glaucoma. 2021. PMID: 33105306
-
One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities.Ophthalmol Ther. 2019 Dec;8(4):563-575. doi: 10.1007/s40123-019-00214-z. Epub 2019 Sep 19. Ophthalmol Ther. 2019. PMID: 31538316 Free PMC article.
-
Second-Generation Trabecular Micro-Bypass (iStent inject) with Cataract Surgery in Eyes with Normal-Tension Glaucoma: One-Year Outcomes of a Multi-Centre Study.Ophthalmol Ther. 2020 Sep;9(3):585-596. doi: 10.1007/s40123-020-00266-6. Epub 2020 Jul 1. Ophthalmol Ther. 2020. PMID: 32613589 Free PMC article.
-
Standalone iStent Trabecular Micro-bypass Glaucoma Surgery: A Systematic Review and Meta-Analysis.J Glaucoma. 2021 Jul 1;30(7):606-620. doi: 10.1097/IJG.0000000000001805. J Glaucoma. 2021. PMID: 33596009
-
Ab interno trabecular bypass surgery with iStent for open-angle glaucoma.Cochrane Database Syst Rev. 2019 Mar 28;3(3):CD012743. doi: 10.1002/14651858.CD012743.pub2. Cochrane Database Syst Rev. 2019. PMID: 30919929 Free PMC article.
Cited by
-
Comparison of Phacoemulsification Alone and With Trabecular Microbypass Stent in Primary Open-Angle Glaucoma and Normal-Tension Glaucoma: An 18-Month Outcome Study.J Ophthalmol. 2024 Nov 7;2024:4034215. doi: 10.1155/2024/4034215. eCollection 2024. J Ophthalmol. 2024. PMID: 39544960 Free PMC article.
-
Five-Year Outcomes of Single Trabecular Microbypass Stent (iStent®) Implantation with Phacoemulsification in Korean Patients.Ophthalmol Ther. 2023 Dec;12(6):3281-3294. doi: 10.1007/s40123-023-00824-8. Epub 2023 Oct 4. Ophthalmol Ther. 2023. PMID: 37792244 Free PMC article.
-
Rates of visual field change and functional progression in glaucoma following trabecular microbypass implantation of iStent technologies: a meta-analysis.BMJ Open Ophthalmol. 2024 Feb 15;9(1):e001575. doi: 10.1136/bmjophth-2023-001575. BMJ Open Ophthalmol. 2024. PMID: 38360043 Free PMC article. Review.
-
Consistency in Standalone Canaloplasty Outcomes Using the iTrack Microcatheter.Clin Ophthalmol. 2024 Jan 16;18:173-183. doi: 10.2147/OPTH.S441113. eCollection 2024. Clin Ophthalmol. 2024. PMID: 38250597 Free PMC article.
-
New Devices in Glaucoma.Ophthalmol Ther. 2023 Oct;12(5):2381-2395. doi: 10.1007/s40123-023-00780-3. Epub 2023 Aug 9. Ophthalmol Ther. 2023. PMID: 37558818 Free PMC article. Review.
References
-
- Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. - PubMed
-
- Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312–334. - PubMed
-
- Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008;17(5):350–355. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous